New classification for identifying HR myeloma based on cytogenetic abnormalities
New classification for identifying HR myeloma based on cytogenetic abnormalities
Predicting tumour mutations from pathology images may help increase personalised medicine utilisation
Choosing Wisely for young women with breast cancer: Radiotherapy
Cancer mutation prediction using artificial intelligence
Whole body-MRI and fluorine 18 fluorodeoxyglucose PET/CT shows promising diagnostic accuracy in multiple myeloma patients
Best practice in HRRm testing in patients with metastatic prostate cancer
Bone disease evaluation of newly diagnosed MM with combined use of 18F-FDG PET/CT and whole-body diffusion weighted MRI
Africa's Medical Physics Workforce
SABCS 2023: Latest breast cancer diagnostics guidelines